Dr Kavita Patel, a practicing physician and a policy researcher at the Brookings Institution, writes in her opinion piece that Obamacare has achieved it's purported goals.
The Affordable Care Act had three main priorities: to improve access to health care, control the growing cost of health care spending and improve the quality of services delivered to Americans. Prior to the Affordable Care Act, our system was broken — family premiums for employer coverage doubled over ten years, and in 2009, health spending reached nearly 18 percent of the gross domestic product. Finally, the United States lagged behind other similar countries on infant mortality, obesity and hospital-acquired infections.
As a practicing physician and a policy researcher, I can say that improvements in all three key priority areas are really happening. One of my newest patients is a 52-year-old woman with progressively debilitating shortness of breath. She was working two part-time jobs as a waitress, and could not previously afford health insurance until the Affordable Care Act. I found out she had undiagnosed heart disease, which we were able to diagnose and treat. I am also making sure that she receives other important preventive services, such as breast cancer detection and immunizations. Her quality of life was improved dramatically in a matter of weeks, thanks in large part to the the health care law.
But it’s not just stories from doctors’ offices — we are seeing signs of success across the country.
Read the complete article on the Brookings website: http://brook.gs/12lU1LN
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More